Edita Navratilova

Mar 13, 2024 | journals.sagepub.com | Frank Porreca |Edita Navratilova |Joe Hirman |Richard Lipton

Conclusion/InterpretationPublished data evaluating the acute treatment effects of gepant drugs from more than 2595 women and 422 men show significant effects on PF and MBS outcomes in women but the available data do not show significant effects in men. The magnitude of the TE observed was always larger in women than in men. Additionally, the calculated NNTs were higher for men than for women for all gepant studies.